
Bicara Therapeutics Inc. Common Stock
USD20.00
+0.36 (+1.83%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.63
Prev. Close
$19.64
Day Low
$19.09
Day High
$20.26
52W Low
$8.48
52W High
$24.25
Market Cap
$1.10B
Volume
0.55M
| 31 Mar 2026 |
| Citizens |
| Market Outperform |
| Market Outperform |
| maintain |
| 31 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 31 Mar 2026 | Goldman Sachs | Neutral | Neutral | maintain |
| 31 Mar 2026 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 13 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 11 Nov 2025 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 22 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |